VLPvacciner
VLPvacciner refers to a category of vaccines that utilize virus-like particles (VLPs) as the primary immunogen. VLPs are structurally similar to infectious viruses but lack genetic material, rendering them non-infectious while retaining the ability to elicit an immune response. This technology has become a cornerstone in modern vaccine development due to its safety profile and effectiveness.
VLPs are assembled spontaneously from viral structural proteins expressed in host cells, such as bacteria, yeast,
The development of VLP-based vaccines began in the 1980s with the first commercialized product, the hepatitis
Advantages of VLP vaccines include their stability, ease of production, and strong immunogenicity. They do not
VLPvacciner technology remains a key innovation in vaccine science, offering a balance between safety and efficacy